Prof. Shubham Pant

Go Back

Medical Oncologist

  • MD Anderson Cancer Center
  • location United States

Dr. Shubham Pant is a Professor in the Department of Gastrointestinal (GI) Medical Oncology with a joint appointment in the Department of Investigational Cancer Therapeutics (Phase I Center) at The University of Texas MD Anderson Cancer Center. Dr. Pant is recognised as an international expert in GI cancers with an emphasis on pancreatic and biliary cancers and Phase 1 trials.

 

Dr. Pant's research focuses on novel immunotherapeutic approaches and targeted therapies in GI cancers, including devising novel ways to target the KRAS mutation. He has been the lead/co-lead of several global practice-changing studies, including 'Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicenter, single-arm, phase 2b study'; 'Adagrasib in advanced solid tumors harboring a KRASG12C mutation' and 'Erdafitinib in patients with advanced solid tumors with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study'; amongst others. He has over 100 peer-reviewed publications and has published in high-impact journals, including The Lancet, Lancet Oncology, and Journal of Clinical Oncology. He is frequently invited to present his research at national and international meetings. He collaborates on numerous grants, including R01 and SPORE grants funded by the National Institute of Health. Dr. Pant serves on the National Cancer Institute (NCI) Pancreas Task Force and the Pancreatic Cancer Action Network's (PanCan) Scientific and Medical Advisory Board. He also helped draft the American Society of Clinical Oncology (ASCO) Metastatic Pancreatic Cancer Guidelines, which provide evidence-based recommendations for physicians. He is also the editor of the book Pancreatic Cancer: Current Therapeutics and Future Directions (Publisher: Springer).

Prof. Shubham Pant has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Consulting or advisory Role: Zymeworks, Ipsen, Novartis, Janssen, AskGene Pharma, BPGBio, Jazz, AstraZeneca, Boehringer Ingelheim, USWorldmeds, Nihon Medi-Physics Co, Ltd, Alligator Bioscience, Theriva Biosciences.

Research funding (funding to institution): Mirati Therapeutics, Lilly, Xencor, Novartis, Bristol-Myers Squibb, Astellas, Framewave, 4D Pharma, Boehringer Ingelheim, NGM Pharmaceuticals, Janssen, Arcus, Elicio, Biontech, Ipsen, Zymeworks, Pfizer, ImmunoMET, Immuneering, Amal Therapeutics.

Programmes developed by Prof. Shubham Pant

podcast Podcast
Oncology 
Interpreting real-world evidence in later-line mCRC

Aligning real-world evidence with clinical trial data 

Experts
Prof. Tanios Bekaii-Saab, Prof. Shubham Pant
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar May 2024

Educational programme supported by an Independent Educational Grant from Bayer.
podcast Podcast
Oncology 
Podcast: How Can We Optimise Treatment Sequencing for mCRC Patients, 3rd Line and Beyond?

Experts discuss how physicians can use the latest data to support optimal treatment sequencing

Experts
Prof. Jenny Seligmann, Prof. Shubham Pant
  • download Downloadable
    Resources
  • clock MIN
  • calendar Apr 2023

Educational programme supported by an Independent Educational Grant from Bayer

Episode

2

of 2

episode
Oncology 
Update from ASCO GI 2023

Episode 2: Lower GI highlights

Experts
Asst. Prof. Efrat Dotan, Dr Nataliya Uboha, Prof. Shubham Pant, Prof. Andrea Sartore-Bianchi
  • download Downloadable
    Resources
  • clock 24 MIN
  • calendar Jan 2023

Educational programme supported by an Independent Educational Grant from Bayer

Episode

1

of 2

episode
Oncology 
Update from ASCO GI 2023

Episode 1: Upper GI cancer highlights

Experts
Asst. Prof. Efrat Dotan, Dr Nataliya Uboha, Prof. Shubham Pant, Prof. Andrea Sartore-Bianchi
  • download Downloadable
    Resources
  • clock 25 MIN
  • calendar Jan 2023

Educational programme supported by an Independent Educational Grant from Bayer
Oncology 
Review paper on treatment sequencing in metastatic colorectal cancer

Experts
Prof. Shubham Pant, Prof. Andrea Sartore-Bianchi, Dr Dominik Modest
  • download Downloadable
    Resources
  • clock 30 MIN
  • calendar Oct 2021

Educational programme supported by an Independent Educational Grant from Bayer
Oncology 
Review paper on K-Ras targeted therapy in GI cancer

Experts
Prof. Shubham Pant, Assoc. Prof. Joleen Hubbard, Prof. Tanios Bekaii-Saab
  • download Downloadable
    Resources
  • clock MIN
  • calendar Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer